320 related articles for article (PubMed ID: 11279265)
1. Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from death.
Cross DA; Culbert AA; Chalmers KA; Facci L; Skaper SD; Reith AD
J Neurochem; 2001 Apr; 77(1):94-102. PubMed ID: 11279265
[TBL] [Abstract][Full Text] [Related]
2. GSK-3 inhibition by adenoviral FRAT1 overexpression is neuroprotective and induces Tau dephosphorylation and beta-catenin stabilisation without elevation of glycogen synthase activity.
Culbert AA; Brown MJ; Frame S; Hagen T; Cross DA; Bax B; Reith AD
FEBS Lett; 2001 Nov; 507(3):288-94. PubMed ID: 11696357
[TBL] [Abstract][Full Text] [Related]
3. Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription.
Coghlan MP; Culbert AA; Cross DA; Corcoran SL; Yates JW; Pearce NJ; Rausch OL; Murphy GJ; Carter PS; Roxbee Cox L; Mills D; Brown MJ; Haigh D; Ward RW; Smith DG; Murray KJ; Reith AD; Holder JC
Chem Biol; 2000 Oct; 7(10):793-803. PubMed ID: 11033082
[TBL] [Abstract][Full Text] [Related]
4. Glycogen synthase kinase-3 inhibitors protect central neurons against excitotoxicity.
Facci L; Stevens DA; Skaper SD
Neuroreport; 2003 Aug; 14(11):1467-70. PubMed ID: 12960765
[TBL] [Abstract][Full Text] [Related]
5. The B cell antigen receptor regulates the transcriptional activator beta-catenin via protein kinase C-mediated inhibition of glycogen synthase kinase-3.
Christian SL; Sims PV; Gold MR
J Immunol; 2002 Jul; 169(2):758-69. PubMed ID: 12097378
[TBL] [Abstract][Full Text] [Related]
6. Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation.
Desbois-Mouthon C; Cadoret A; Blivet-Van Eggelpoël MJ; Bertrand F; Cherqui G; Perret C; Capeau J
Oncogene; 2001 Jan; 20(2):252-9. PubMed ID: 11313952
[TBL] [Abstract][Full Text] [Related]
7. Lithium inhibits neurite growth and tau protein kinase I/glycogen synthase kinase-3beta-dependent phosphorylation of juvenile tau in cultured hippocampal neurons.
Takahashi M; Yasutake K; Tomizawa K
J Neurochem; 1999 Nov; 73(5):2073-83. PubMed ID: 10537067
[TBL] [Abstract][Full Text] [Related]
8. Opposing actions of phosphatidylinositol 3-kinase and glycogen synthase kinase-3beta in the regulation of HSF-1 activity.
Bijur GN; Jope RS
J Neurochem; 2000 Dec; 75(6):2401-8. PubMed ID: 11080191
[TBL] [Abstract][Full Text] [Related]
9. Glycogen synthase kinase-3 beta activity is critical for neuronal death caused by inhibiting phosphatidylinositol 3-kinase or Akt but not for death caused by nerve growth factor withdrawal.
Crowder RJ; Freeman RS
J Biol Chem; 2000 Nov; 275(44):34266-71. PubMed ID: 10954722
[TBL] [Abstract][Full Text] [Related]
10. Glycogen synthase kinase-3 couples AKT-dependent signaling to the regulation of p21Cip1 degradation.
Rössig L; Badorff C; Holzmann Y; Zeiher AM; Dimmeler S
J Biol Chem; 2002 Mar; 277(12):9684-9. PubMed ID: 11779850
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia activates a platelet-derived growth factor receptor/phosphatidylinositol 3-kinase/Akt pathway that results in glycogen synthase kinase-3 inactivation.
Chen EY; Mazure NM; Cooper JA; Giaccia AJ
Cancer Res; 2001 Mar; 61(6):2429-33. PubMed ID: 11289110
[TBL] [Abstract][Full Text] [Related]
12. Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons.
Chalecka-Franaszek E; Chuang DM
Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8745-50. PubMed ID: 10411946
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factor 1 regulates signaling via the glycogen synthase kinase-3beta pathway. Implications for neuroprotection.
Hashimoto M; Sagara Y; Langford D; Everall IP; Mallory M; Everson A; Digicaylioglu M; Masliah E
J Biol Chem; 2002 Sep; 277(36):32985-91. PubMed ID: 12095987
[TBL] [Abstract][Full Text] [Related]
14. Essential role for protein kinase B (PKB) in insulin-induced glycogen synthase kinase 3 inactivation. Characterization of dominant-negative mutant of PKB.
van Weeren PC; de Bruyn KM; de Vries-Smits AM; van Lint J; Burgering BM
J Biol Chem; 1998 May; 273(21):13150-6. PubMed ID: 9582355
[TBL] [Abstract][Full Text] [Related]
15. Lipopolysaccharide activates Akt in human alveolar macrophages resulting in nuclear accumulation and transcriptional activity of beta-catenin.
Monick MM; Carter AB; Robeff PK; Flaherty DM; Peterson MW; Hunninghake GW
J Immunol; 2001 Apr; 166(7):4713-20. PubMed ID: 11254732
[TBL] [Abstract][Full Text] [Related]
16. Corticotropin-releasing factor (CRF) and related peptides confer neuroprotection via type 1 CRF receptors.
Facci L; Stevens DA; Pangallo M; Franceschini D; Skaper SD; Strijbos PJ
Neuropharmacology; 2003 Oct; 45(5):623-36. PubMed ID: 12941376
[TBL] [Abstract][Full Text] [Related]
17. Roles of Akt and glycogen synthase kinase 3beta in the ultraviolet B induction of cyclooxygenase-2 transcription in human keratinocytes.
Tang Q; Gonzales M; Inoue H; Bowden GT
Cancer Res; 2001 Jun; 61(11):4329-32. PubMed ID: 11389054
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of GSK-3 selectively reduces glucose-6-phosphatase and phosphatase and phosphoenolypyruvate carboxykinase gene expression.
Lochhead PA; Coghlan M; Rice SQ; Sutherland C
Diabetes; 2001 May; 50(5):937-46. PubMed ID: 11334436
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E and beta-amyloid (1-42) regulation of glycogen synthase kinase-3beta.
Cedazo-Mínguez A; Popescu BO; Blanco-Millán JM; Akterin S; Pei JJ; Winblad B; Cowburn RF
J Neurochem; 2003 Dec; 87(5):1152-64. PubMed ID: 14622095
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A.
Fang X; Yu SX; Lu Y; Bast RC; Woodgett JR; Mills GB
Proc Natl Acad Sci U S A; 2000 Oct; 97(22):11960-5. PubMed ID: 11035810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
